Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Related Citations for PubMed (Select 22949570)

1.

Perceived treatment assignment and smoking cessation in a clinical trial of bupropion versus placebo.

Buchanan TS, Sanderson Cox L, Thomas JL, Nollen NL, Berg CJ, Mayo MS, Ahluwalia JS.

Nicotine Tob Res. 2013 Feb;15(2):567-71. doi: 10.1093/ntr/nts143. Epub 2012 Sep 4.

2.

Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.

Cox LS, Nollen NL, Mayo MS, Choi WS, Faseru B, Benowitz NL, Tyndale RF, Okuyemi KS, Ahluwalia JS.

J Natl Cancer Inst. 2012 Feb 22;104(4):290-8. doi: 10.1093/jnci/djr513. Epub 2012 Jan 25.

3.

The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers.

Thomas JL, Guo H, Lynam IM, Powell JN, Okuyemi KS, Bronars CA, Ahluwalia JS.

J Gen Intern Med. 2008 Sep;23(9):1361-6. doi: 10.1007/s11606-008-0656-3. Epub 2008 Jun 29.

4.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
5.

Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.

Faseru B, Nollen NL, Mayo MS, Krebill R, Choi WS, Benowitz NL, Tyndale RF, Okuyemi KS, Ahluwalia JS, Sanderson Cox L.

Addict Behav. 2013 Mar;38(3):1796-803. doi: 10.1016/j.addbeh.2012.11.010. Epub 2012 Nov 29.

6.

Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion.

Harris KJ, Okuyemi KS, Catley D, Mayo MS, Ge B, Ahluwalia JS.

Prev Med. 2004 Apr;38(4):498-502.

PMID:
15020185
7.

Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial.

Sheng LX, Tang YL, Jiang ZN, Yao CH, Gao JY, Xu GZ, Tong XY.

Nicotine Tob Res. 2013 Feb;15(2):320-5. doi: 10.1093/ntr/nts124. Epub 2012 May 21.

PMID:
22614545
8.

Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.

Schnoll RA, Epstein L, Audrain J, Niaura R, Hawk L, Shields PG, Lerman C, Wileyto EP.

J Subst Abuse Treat. 2008 Mar;34(2):234-41. Epub 2007 Jun 27.

9.

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.

10.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006103. doi: 10.1002/14651858.CD006103.pub6. Review.

PMID:
22513936
11.

Bupropion for smoking cessation : predictors of successful outcome.

Dale LC, Glover ED, Sachs DP, Schroeder DR, Offord KP, Croghan IT, Hurt RD.

Chest. 2001 May;119(5):1357-64.

PMID:
11348939
12.

Development of depression during placebo-controlled trials of bupropion for smoking cessation: case reports.

Patten CA, Rummans TA, Croghan IT, Hurt RD, Hays JT.

J Clin Psychiatry. 1999 Jul;60(7):436-41.

PMID:
10453796
13.

A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.

Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S; General Practice Tobacco Cessation Investigators Group.

Arch Intern Med. 2007 Sep 10;167(16):1791-7.

PMID:
17846399
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
15.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
16.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
17.

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.

Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B.

Lancet. 2001 May 19;357(9268):1571-5.

PMID:
11377644
18.

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

Ann Intern Med. 2001 Sep 18;135(6):423-33.

PMID:
11560455
19.

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

Gonzales D, Jorenby DE, Brandon TH, Arteaga C, Lee TC.

Addiction. 2010 Nov;105(11):2002-13. doi: 10.1111/j.1360-0443.2010.03058.x. Epub 2010 Sep 1.

20.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk